Study of a frailty screening tool for older adults with cancer
Part of Cancer clinical trials.
This study tests a simple questionnaire called the G8 to see how well it predicts frailty and early death in people aged 70 or older with cancer. It aims to help doctors better plan treatment for older patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older
- You have been diagnosed with a solid tumor cancer (not skin cancer that is not melanoma)
- Your cancer has spread to other parts of the body or has come back, and you have not yet received treatment for this stage
- You are about to start your first line of systemic therapy (like chemotherapy, targeted therapy, or immunotherapy)
- You are able to understand and sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a short screening questionnaire called G8 to see how well it helps doctors assess the health and needs of older adults (70+) with solid tumors before starting cancer treatment. If you join, you'll answer some simple questions about your daily life and overall health.
This trial is testing a simple health questionnaire (the sG8) for older adults with cancer. The goal is to see if this screening tool helps doctors better understand your overall health and plan your treatment. It is for people aged 65 and older who are about to start a systemic therapy (like chemo or immunotherapy).
This study is developing a simple screening tool to help doctors better understand the overall health and needs of older cancer patients (65+). It aims to make sure elderly patients get the right support during cancer treatment.
This study compares different ways to check frailty (a measure of how well your body handles stress) in women with breast cancer who are 50 or older. The goal is to find which screening tool best predicts health outcomes during treatment.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.